These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8373202)

  • 1. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432].
    Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1443-5. PubMed ID: 8373202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of cytokine levels in ascitic fluid after intraperitoneal administration of OK-432 or CDDP].
    Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2326-9. PubMed ID: 7944471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
    Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
    Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal administration of the biological response modifier OK-432 and peritoneal recurrence following gastrectomy.
    Tsujitani S; Abe Y; Korenaga D; Saitoh A; Watanabe A; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):498-502. PubMed ID: 2253926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
    Kawaoka T; Yoshino S; Kondo H; Yamamoto K; Hazama S; Oka M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intratumoral OK-432 administration of thymidine phosphorylase expression in human gastric carcinoma.
    Ogawa K; Konno S; Takebayashi Y; Murayama M; Shimakawa T; Katsube T; Naritaka Y; Kajiwara T; Aiba M; Akiyama S
    Anticancer Res; 2001; 21(2B):1257-62. PubMed ID: 11396196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells.
    Morisaki T; Matsunaga H; Beppu K; Ihara E; Hirano K; Kanaide H; Mori M; Katano M
    Anticancer Res; 2000; 20(5B):3363-73. PubMed ID: 11131636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
    Neda H; Watanabe N; Sone H; Yamauchi N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of intraperitoneal administration of OK-432 with recombinant interleukin-2 to patients with peritonitis carcinomatosa of recurrent gynecological cancer and changes in ascitic lymphocyte subsets].
    Kanaoka Y; Umesaki N
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):489-96. PubMed ID: 2056223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effect of intraperitoneal administration of CDDP and OK-432 in peritonitis carcinomatosa cases in postoperative gastric carcinoma].
    Tanaka T; Itoi H; Matsui S; Nakae A; Nagashima K
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):661-3. PubMed ID: 2012407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination].
    Kajiura Y; Ogoshi K; Nakamura K; Miyaji M; Kondoh Y; Makuuchi H; Tajima T; Mitomi T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1863-6. PubMed ID: 9382552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
    Saxena N; Aggarwal A; Misra R
    J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
    Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of endoscopic local injection of OK-432 on regional lymph nodes in gastric cancer patients].
    Ogawara T; Sakai K; Sekikawa T; Kouno K; Matsumoto Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1601-4. PubMed ID: 1530316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal fluid cytokines and sICAM-1 in minimal endometriosis: search for discriminating factors between infertility and/or endometriosis.
    Skrzypczak J; Szczepańska M; Puk E; Kamieniczna M; Kurpisz M
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):95-103. PubMed ID: 16154044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432.
    Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G
    Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.